Japanese

Department of Clinical Product Development

Clinical Product Development department is one of the departments in the Clinical Medicine and Research was established newly on April 1, 2012.

Department of Pediatric Infectious DiseasesThis is a newly established department in response to the Global Strategy on public health, innovation and intellectual property (resolution WHA61.21). The resolution calls for the enhancement of health-needs driven research and development to address diseases that disproportionately affect developing countries. The establishment of this department was supported by the Department of Academic and Research Promotion, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. MEXT continues to support the department until its full development.

Members

  • Professor Laothavorn Juntra
  • Associate Professor Nguyen Huy Tien
  • Assistant Professor Syusaku Mizukami
  • Visiting Professor Kesara Na-Bangchang
  • Visiting Researcher Tullayakorn Plengsuriyakarn
  • Assistant Sayuri Delaney
  • Graduate Student Nut Koonrungsesomboon
  • Graduate Student Martha Lemma

To the Site of our department»

The department focuses on

  1. building capacity of individuals for innovation in health product.
  2. strengthening capability of the local research institutions in providing an enabling environment, including infrastructure for product R&D.
  3. strengthening research institutes network for knowledge sharing and exchange, and for R&D technology transfer activities. The emphasis will be on developing products for public health needs to address the issues of inequity in health.
  4. Development of health products.

The operation of this department depends on the collaboration of existing offices and departments in NEKKEN and in Nagasaki University, e.g. Office for Training and Education, Immunogenetics, Toxicology, Clinical Pharmacy, Parasitology, Clinical Medicine, Clinical Paediatrics, Center for infectious disease research in Asia and Africa and the research institutions and universities in developing countries. The aim of its operation is to ensure that research priorities of research institutions are in line with their public-health needs, in particular the need for innovative research to address the health problems of their populations and to contribute to improved public health in other countries.

The activities

a) Training

  1. Two- week course on Product Research and Development for public health needs;
  2. Three-day course on Bioethics;
  3. PhD training as part of actual product development ie. Shiunko for Cutaneous Leishmaniasis, Herbal Medicine for Cholangiocarcinoma and Malaria (see model below);
  4. PhD training as part of associated product development processes e.g. ethical issues in product development, clinical data management, good laboratory practice and etc.

b) Research

  1. Development of Shiunko for Cutaneous Leishmaniasis;
  2. Identification and further development of Herbal Medicine for Breast cancer, Cholangiocarcinoma and Malaria.

c) Network

  1. Coordination of Product Research and Development (PRD) Network
  2. Coordination of research ethics global network-Strategic Initiative for Developing Capacity in Ethical Review (SIDCER)

Collaborations

  1. Drug Research Center, Thammasat University, Bangkok, Thailand
  2. Forum for Ethical Review Committees in the Asian and Western Pacific Region (FERCAP), Bangkok, Thailand
  3. Armauer Hansen Research Institute, Ministry of Health, Addis Ababa, Ethiopia
  4. Institution of Human Research Protection, Ministry of Health, Thailand
  5. Tokyo University, Tokyo, Japan
  6. Government Pharmaceutical Organization, Bangkok, Thailand

Return to Top of Department»